secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2026-08-11T10:47:32+00:00
Accession:  0000721371-26-000037
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q4 revenue up 6% to $63.7B; FY26 non-GAAP EPS $11.26, up 37%
----------------------------------------------------------------------------

- Q4 revenue $63.7B (+6% YoY); GAAP diluted EPS $1.70 (+70%); non-GAAP EPS $2.91 (+40%), incl. $0.31 IEEPA refund.
- FY26 revenue $254.2B (+14%); non-GAAP EPS $11.26 (+37%); excluding IEEPA refund, EPS $10.95 (+33%).
- Board approved $5.0B incremental buyback; FY26 repurchases totaled $1.4B, new authorization $6.4B.
- FY27 guidance: non-GAAP EPS $12.40-$12.60 (+13% to +15%); segment profit growth guided 8-18%.
- Pharma segment profit +21%; GMPD profit $150M on IEEPA refunds; dividend $0.5158/share payable Oct 15.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137126000037/0000721371-26-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137126000037/cah-20260811.htm
  HTML page:      https://secwatch.observer/filing/0000721371-26-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer